Shopping Cart
Remove All
Your shopping cart is currently empty
Isecarosmab (M6495) is a monoclonal antibody targeting ADAMTS-5, capable of protecting cartilage and inhibiting ADAMTS-5-mediated degradation of aggrecan, for use in osteoarthritis (OA) research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $289 | - | In Stock | |
| 5 mg | $745 | - | In Stock | |
| 10 mg | $1,180 | - | In Stock | |
| 25 mg | $1,770 | - | In Stock | |
| 50 mg | $2,380 | - | In Stock |
| Description | Isecarosmab (M6495) is a monoclonal antibody targeting ADAMTS-5, capable of protecting cartilage and inhibiting ADAMTS-5-mediated degradation of aggrecan, for use in osteoarthritis (OA) research. |
| In vitro | In bovine and human osteoarthritis (OA) cartilage samples, Isecarosmab (1-100 nM, 5 days) dose-dependently inhibited the significant release of huARGS and exAGNxI induced by O+T, as well as the release of GAG induced by IL-1α [1]. |
| In vivo | Isecarosmab significantly improved medial cartilage degeneration in mice with destabilization of the medial meniscus (DMM) when administered subcutaneously at doses of 0.1-10 mg/kg every three days [1]. |
| Synonyms | M-6495, M6495 |
| Cas No. | 2254082-79-4 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.